Registry and Biobank Study of Infectious Diseases in Adults
Collecting Clinical, Microbiological, and Treatment Data
Led by IRCCS San Raffaele · Updated on 2026-04-20
10000
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting information about patients with various infectious diseases to create a detailed database and biobank. This observational study focuses on illnesses such as bloodstream infections, central nervous system infections, bone and joint infections, endovascular infections, sexually transmitted infections, HIV infection, and emerging infectious diseases. The goal is to understand the clinical, laboratory, imaging, and microbiological features as well as treatment approaches, and to study factors affecting treatment success and disease outcomes.
Participants will provide biological samples like blood, cerebrospinal fluid, and urine at the start of their infectious disease diagnosis. Data and samples will be collected at baseline, end of treatment, and six months later, or yearly for HIV patients. Additional collections may occur depending on disease progression or treatment changes. The study will record clinical scores, laboratory results, imaging, treatment details, drug levels, and outcomes including mortality and complications.
Participants will be monitored through clinical and laboratory assessments at several time points including baseline, end of treatment, and follow-up visits. Researchers will use these data to analyze disease characteristics, treatment responses, and outcomes over time. The study aims to identify biomarkers, predictors of cure, and factors influencing mortality and complications. Participation involves donating samples and sharing medical information, with follow-up lasting at least six months or longer for some conditions.
CONDITIONS
Brief Title
INfectious DIsease REgistry BIObank
Research Team
E
Elisabetta Carini
S
Sabrina Bagaglio
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients with clinically suspected or microbiologically documented infectious diseases (bacterial, viral, fungal or parasitic)
At least 18 years of age or older
Able to provide informed consent
Participants unable to give consent must have a legal representative
You will not qualify if you...
Participants unable to understand the study protocol or give informed consent and who have no legal representative
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - Up to 6 months after the end of treatment or 6 months after diagnosis if no treatment is given; yearly follow-up for participants with HIV infection
Participants who undergo routine care for infectious diseases are observed. Data and biological samples are collected at baseline and during follow-up to assess clinical, microbiological, and treatment characteristics of their condition.
Baseline visit, end of treatment visit, 6-month follow-up visit; yearly visits for participants with HIV infection
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Diagnostic Trial of Al18FF-NOTA-folate PET Imaging for Suspected Cardiac Sarcoidosis and Infective Endocarditis
Barts Heart Centre Registry Tracking Infective Endocarditis Patient Outcomes and Treatment Effectiveness
Studying Beta-Lactam Antibiotic Levels and Patient Factors in Adults with Infective Endocarditis
Study on Blood Droplet Digital PCR for Early Detection and Monitoring of Pathogenic Bacteria in ICU Patients with Sepsis
3D Imaging Using Cone Beam Computed Tomography Compared to Orthopantomogram to Evaluate Oral Health in Patients Hospitalized for Infective Endocarditis Over 12 Months
Nationwide Study of Adults with Central Nervous System Infections in Denmark
Tracking Diagnosis, Treatment, and Outcomes at Infectious Disease Departments
Testing a Rapid Multiplex PCR Diagnostic to Improve Treatment in Adults With Bloodstream Infections
Comparing Echocardiography to No Echocardiography in Adults with Staphylococcus Aureus Bloodstream Infection and Low VIRSTA Score
Evaluating a Diagnostic Algorithm to Guide Targeted Antibiotic Therapy in Adults with Infective Endocarditis
Study of Changes in Patient Care and Quality of Life for Adults Treated for Spinal Conditions at Bordeaux University Hospital
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research.